Authors

  • Khusniya Ergashzoda
    Central Asian Medical University

DOI:

https://doi.org/10.71337/inlibrary.uz.ijms.120571

Abstract

Pediatric pneumonia remains a leading cause of mortality in children under five, especially in low- and middle-income countries. This paper explores how socioeconomic factors—particularly income, maternal education, and healthcare access—affect pneumonia incidence and outcomes. The protective role of childhood vaccination is also examined, revealing significant disparities in immunization coverage due to financial and infrastructural barriers. Interventions targeting these social determinants are critical to reducing the burden of pediatric pneumonia and achieving sustainable public health improvements.

 

 

background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

PREVENTING PEDIATRIC PNEUMONIA: ROLE OF VACCINATION AND

SOCIOECONOMIC FACTORS

Ergashzoda Khusniya Sharafidin kizi

Central Asian Medical University

E-mail: ergashzodaxusniya@gmail.com

https://orcid.org/0009-0001-6423-3642

Abstract:

Pediatric pneumonia remains a leading cause of mortality in children under five,

especially in low- and middle-income countries. This paper explores how socioeconomic

factors—particularly income, maternal education, and healthcare access—affect pneumonia

incidence and outcomes. The protective role of childhood vaccination is also examined,

revealing significant disparities in immunization coverage due to financial and

infrastructural barriers. Interventions targeting these social determinants are critical to

reducing the burden of pediatric pneumonia and achieving sustainable public health

improvements.

Keywords:

pneumonia, vaccination, income, education, healthcare

Introduction

The incidence of pediatric pneumonia in developing countries is significantly influenced by

income level, education, and access to healthcare, as these factors are deeply intertwined

with the social determinants of health. Low income is a critical risk factor, as evidenced by

studies showing higher pneumonia incidence rates in impoverished areas, such as in Brazil,

where low-income regions exhibited significantly higher rates of pneumonia compared to

wealthier areas[2]. This is further supported by findings from Ethiopia, where

socioeconomic deprivation, including low family income, was associated with a higher

prevalence of pneumonia among children[9]. Education, particularly maternal education,

plays a pivotal role in mitigating pneumonia risk. Higher maternal education levels are

linked to better health-seeking behaviors and reduced pneumonia incidence, as educated

mothers are more likely to recognize symptoms early and seek timely medical

intervention[3] [4]. In Bangladesh, disparities in healthcare-seeking behavior for pneumonia

were observed, favoring educated and urban residents, highlighting the role of education in

accessing healthcare services[6]. Access to healthcare is another crucial determinant, with

limited access exacerbating the burden of pneumonia. In Nepal, children from rural areas,

where healthcare facilities are less accessible, had higher odds of pneumonia, and many did

not receive appropriate treatment[10]. The lack of healthcare access is compounded by poor

healthcare-seeking behaviors, often due to a lack of awareness and education about

pneumonia symptoms and treatment options[1]. Furthermore, vaccination coverage, which is

a preventive healthcare measure, remains inadequate in many low-income settings,

contributing to higher pneumonia rates[5]. Overall, addressing these socioeconomic and

healthcare access disparities through targeted interventions, such as improving education,

increasing healthcare access, and enhancing vaccination coverage, is essential for reducing

the incidence of pediatric pneumonia in developing countries[1] [4] [8].


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Income level and pediatric pneumonia

Income level serves as a crucial and influential factor in determining the prevalence and

incidence rates of pediatric pneumonia among children. Specifically, it has been observed

that children hailing from economically disadvantaged backgrounds and low-income

families are statistically more susceptible to experiencing episodes of pneumonia, which can

be attributed to a multitude of interrelated factors that significantly impact their overall

health and well-being:

1.

Malnutrition and Poor Living Conditions: Low-income households often struggle to

provide adequate nutrition, leading to malnutrition, which weakens a child's immune system

and increases the risk of pneumonia [3] [13].

2.

Exposure to Indoor Air Pollution: Families in low-income settings often rely on

biomass fuels (e.g., wood, charcoal, and dung) for cooking, which produces harmful indoor

air pollutants that can cause respiratory infections, including pneumonia [3] [10].

3.

Limited Access to Preventive Measures: Children from low-income families are less

likely to receive vaccinations, such as the pneumococcal conjugate vaccine (PCV), due to

financial constraints, increasing their vulnerability to pneumonia [5] [19].

Table:

Impact of income level on pediatric pneumonia

Factor

Impact on Pneumonia Incidence

Citation

Low Income

Increased risk due to malnutrition and indoor air

pollution

[3] [13]

Limited

Access

to

Vaccines

Higher vulnerability to pneumonia

[5] [19]

Pediatric pneumonia cannot be addressed solely through clinical interventions; its incidence

is deeply tied to broader societal structures. One of the most influential factors is income

level, as poverty limits access to adequate nutrition, clean environments, and timely medical

treatment. Children in low-income households are at a significantly greater risk of

developing pneumonia due to malnutrition and exposure to indoor air pollutants from

biomass fuel. These risks are compounded by a lack of financial resources to afford

preventive services, such as vaccinations. Targeting economic disparities with poverty-

alleviation programs can indirectly strengthen children's immunity and reduce exposure to

infectious agents.

Education, particularly maternal education, plays a powerful mediating role in preventing

pneumonia. Educated mothers are more likely to recognize early symptoms of respiratory

illness, seek timely medical care, and follow immunization schedules. Moreover, they tend

to practice better hygiene and nutrition habits, further reducing their children’s susceptibility

to infection. Hence, empowering women through educational initiatives is not only a social

good but a public health imperative. National and regional health strategies should integrate

female literacy and health education as key pillars of pneumonia prevention programs.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Access to healthcare services is another major determinant of pneumonia outcomes.

Geographic isolation, inadequate transportation infrastructure, and under-resourced health

facilities pose significant barriers to care, especially in rural areas. Even when care is sought,

lack of diagnostic tools, oxygen therapy, and essential medications can result in poor

outcomes. Enhancing healthcare access requires more than building facilities; it involves

ensuring affordability, continuous supply chains, and well-trained personnel. Expanding

community-based healthcare and mobile outreach programs could bridge the gap for

underserved populations and significantly reduce pneumonia-related mortality.

Education and pediatric pneumonia

Maternal education plays a crucial role in reducing the incidence of pneumonia among

children. Studies have shown that:

1.

Improved Health Knowledge: Educated mothers are more likely to recognize the

signs and symptoms of pneumonia, leading to timely seeking of healthcare services [1] [2].

2.

Better Hygiene Practices: Education enhances awareness of preventive measures,

such as proper handwashing and the use of clean water, which reduce the risk of

pneumonia [9] [12].

3.

Vaccination Uptake: Mothers with higher levels of education are more likely to

ensure their children receive recommended vaccinations, including those that protect against

pneumonia [5] [17].

Table:

Impact of education on pediatric pneumonia

Factor

Impact on Pneumonia Incidence

Citation

Maternal Education Improved recognition of symptoms and timely

healthcare seeking

[1] [2]

Health Knowledge

Increased use of preventive measures

[9] [12]

Vaccination Uptake Higher likelihood of vaccination

[5] [17]

Access to healthcare and pediatric pneumonia

Access to healthcare is another critical factor influencing the incidence of pediatric

pneumonia. Barriers to healthcare access include:

1.

Geographic Constraints: Children in rural areas often face challenges in accessing

healthcare facilities due to long distances and lack of transportation, leading to delays in

seeking care [7] [11].

2.

Financial Barriers: The cost of healthcare services and medications can prevent low-

income families from seeking timely medical care for their children [4] [12].

3.

Quality of Care: In some settings, healthcare facilities may lack the necessary

resources, such as oxygen therapy and antibiotics, to effectively manage pneumonia

cases [4].


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Table:

Impact of access to healthcare on pediatric pneumonia

Factor

Impact on Pneumonia Incidence

Citation

Geographic Constraints

Delays in seeking care

[7] [11]

Financial Barriers

Reduced access to timely medical care

[4] [12]

Quality of Care

Inadequate treatment leading to higher mortality [4]

Combined Impact of Income Level, Education, and Access to Healthcare

The multifaceted and intertwined effects of income level, educational attainment, and

accessibility to healthcare services engender a pernicious cycle that disproportionately

burdens children who are situated in economically disadvantaged environments. Families

that are grappling with poverty frequently encounter a myriad of interconnected challenges,

which encompass not only a scarcity of financial resources but also a deficiency in

educational opportunities, as well as insufficient access to essential healthcare services, all

of which cumulatively exacerbate the likelihood of contracting pneumonia and intensify its

severity among affected individuals.

Table:

Combined impact of factors on pediatric pneumonia

Factor

Impact on Pneumonia Incidence

Citation

Low Income and Poor

Education

Increased risk due to malnutrition and lack of

preventive measures

[3] [13]

Limited

Access

to

Healthcare

Delays in seeking care and inadequate treatment

[7] [11]

Socioeconomic

Disparities

Higher mortality rates in disadvantaged groups

[5] [19]

Conclusion

The prevalence of pediatric pneumonia within the context of developing nations is

profoundly shaped by a confluence of factors, including, but not limited to, the

socioeconomic status indicated by income levels, the educational attainment of the

population, and the degree of accessibility to quality healthcare services. To effectively

tackle and ameliorate these critical determinants, it is imperative to adopt a comprehensive

and multifaceted strategy that encompasses not only initiatives aimed at alleviating poverty,

but also robust educational programs and significant enhancements to the healthcare

infrastructure and its overall accessibility for marginalized communities. By strategically

directing resources and efforts toward these essential areas, policymakers and healthcare

practitioners can significantly diminish the incidence and impact of pneumonia among the

pediatric population residing in low- and middle-income countries (LMICs).


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

References

:

1.

Adhamjon o'g, A. A. Z., & Mo'minjonovna, M. B. (2025, May). CLINICAL

PHARMACOLOGY OF ANTI-INFLAMMATORY DRUGS. In

CONFERENCE OF

MODERN SCIENCE & PEDAGOGY

(Vol. 1, No. 2, pp. 88-91).

2.

Boboxonova, M. (2025). COMBATING EARLY MENOPAUSE: MODERN

MEDICAL APPROACHES AND NATURAL TREATMENT METHODS.

International

Journal of Artificial Intelligence

,

1

(4), 56-59.

3.

Boretskaya, A. S. (2025). VIRAL VECTORS. STUDY AND RESEARCH OF DNA

AND RNA CONTAINING VIRUSES.

Western European Journal of Medicine and Medical

Science

,

3

(05), 38-41.

4.

Boretskaya, A., Farid, M. E., Egorova, S., & Lamberov, A. (2022). Transformation

of amorphous aluminum oxide in the catalytic dehydration reaction of aromatic alcohol.

5.

Ganiyeva M. R. CLINICAL AND MORPHOFUNCTIONAL CHANGES IN THE

RETINA IN HIGH MYOPIA IN COMBINATION WITH AGE-RELATED MACULAR

DEGENERATION OF DIFFERENT STAGES //International Conference on Modern

Science and Scientific Studies. – 2024. – С. 141-142.

6.

Ikromova,

N.

(2024).

TABIIY

SIANOGLIKOZID-AMIGDALINNING

KIMYOVIY XOSSALARI VA AMALIY AHAMIYATI.

Universal xalqaro ilmiy

jurnal

,

1

(6), 26-29.

7.

Ikromova, N. (2024, October). AMIGDALIN HOSILALARI SINTEZI

ISTIQBOLLARI. In

CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE

IN THE MODERN WORLD

(Vol. 1, No. 8, pp. 164-166).

8.

Mo’Minjonovna, B. M., & O’G’Li, M. A. R. (2024). STUDY AND ANALYSIS OF

THE PHARMACOLOGICAL PROPERTIES OF MEDICINAL PLANTS, WHICH ARE

CARDIAC GLYCOSIDES USED IN CLINICAL PRACTICE.

Eurasian Journal of

Medical and Natural Sciences

,

4

(1-1), 80-83.

9.

Raqiboyevna, G. M., & Abdulhay, M. (2025). PREVENTION OF

COMPLICATIONS OF CARDIOVASCULAR DISEASES BY ORGANIZING

MORPHOLOGICAL AND CLINICAL INDICATORS OF ARCUS SENILIS.

Modern

education and development

,

26

(4), 201-204.

10.

Raqiboyevna, G. M., & Abdulhay, M. (2025, May). MORPHOLOGICAL AND

CLINICAL INDICATIONS OF COMPLICATIONS OF CARDIOVASCULAR DISEASE

ARCUS SENILIS. In

International Conference on Multidisciplinary Sciences and

Educational Practices

(pp. 182-184).

11.

Бобохонова, М. М., & Дехконбоева, К. А. (2021). НАЦИОНАЛЬНАЯ МОДЕЛЬ

ОХРАНЫ ЗДОРОВЬЯ МАТЕРИ И РЕБЕНКА В УЗБЕКИСТАНЕ:" ЗДОРОВАЯ

МАТЬ-ЗДОРОВЫЙ РЕБЕНОК".

Экономика и социум

, (10 (89)), 540-543.

12.

Борецкая, А. С. (2022). СОСТОЯНИЕ ОБРАЗОВАНИЯ И ПЕДАГОГИЧЕСКОЙ

МЫСЛИ В ЭПОХУ БЕРУНИ.

Academic research in educational sciences

, (3), 125-127.

13.

Борецкая, А. С., Расулов, Ф. Х., Рузалиев, К. Н., & Хасанов, Н. Ф. У. (2024).

ИММУНОГЕНЕЗ

И

МИКРОФЛОРА

КИШЕЧНИКА

ПРИ

ПАТОЛОГИИ

СМЕШАННОЙ ЭТИОЛОГИИ И ПУТИ ИХ КОРРЕКЦИИ.

Science and

innovation

,

3

(Special Issue 45), 276-281.

14.

Икромова, Н. М. (2024). Научно-Теоретические Основы Социальной

Адаптации Старшего Дошкольника На Основе Речевого Развития.

Miasto

Przyszłości

,

54

, 385-387.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Ju

ne

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

15.

Икромова, Н., & Эминов, Р. (2025). Влияние эмоционального интеллекта и

уровня тревожности на развитие речи и социальную адаптацию детей дошкольного

возраста.

in Library

,

1

(2), 15-19.

16.

Икромова, Н., & Эминов, Р. (2025). Развитие речи и языка у дошкольников:

роль родительского взаимодействия.

in Library

,

1

(2), 28-32.

17.

Расулов, Ф. Х., Борецкая, А. С., Маматкулова, М. Т., & Рузибаева, Ё. Р. (2024).

INFLUENCE AND STUDY OF MEDICINAL PLANTS OF UZBEKISTAN ON THE

IMMUNE SYSTEM.

Web of Medicine: Journal of Medicine, Practice and Nursing

,

2

(12),

118-124.

18.

Расулов, Ф., Тожалиевна, М., Рузибаева, Ё., & Борецкая, А. (2024).

Исследование

стабильной

формы

коронавируса

и

ее

устойчивости

к

изменчивости.

Профилактическая медицина и здоровье

,

3

(3), 20-26.

19.

Тешабоев, А. М., Юлчиева, С. Т., Расулов, У. М., Борецкая, А. С., & Расулов, Ф.

Х. ИЗУЧЕНИЕ ИММУНОГЕНЕЗА И ГЕМОПОЭЗА У ЖИВОТНЫХ С ТИ-ПОМ

АЦЕТИЛИРОВАНИЯ И ПУТИ ИХ КОРРЕКЦИИ С ОЧИЩЕННЫМ КОМПЛЕКСОМ

ДЕТОКСИОМЫ.

References

Adhamjon o'g, A. A. Z., & Mo'minjonovna, M. B. (2025, May). CLINICAL PHARMACOLOGY OF ANTI-INFLAMMATORY DRUGS. In CONFERENCE OF MODERN SCIENCE & PEDAGOGY (Vol. 1, No. 2, pp. 88-91).

Boboxonova, M. (2025). COMBATING EARLY MENOPAUSE: MODERN MEDICAL APPROACHES AND NATURAL TREATMENT METHODS. International Journal of Artificial Intelligence, 1(4), 56-59.

Boretskaya, A. S. (2025). VIRAL VECTORS. STUDY AND RESEARCH OF DNA AND RNA CONTAINING VIRUSES. Western European Journal of Medicine and Medical Science, 3(05), 38-41.

Boretskaya, A., Farid, M. E., Egorova, S., & Lamberov, A. (2022). Transformation of amorphous aluminum oxide in the catalytic dehydration reaction of aromatic alcohol.

Ganiyeva M. R. CLINICAL AND MORPHOFUNCTIONAL CHANGES IN THE RETINA IN HIGH MYOPIA IN COMBINATION WITH AGE-RELATED MACULAR DEGENERATION OF DIFFERENT STAGES //International Conference on Modern Science and Scientific Studies. – 2024. – С. 141-142.

Ikromova, N. (2024). TABIIY SIANOGLIKOZID-AMIGDALINNING KIMYOVIY XOSSALARI VA AMALIY AHAMIYATI. Universal xalqaro ilmiy jurnal, 1(6), 26-29.

Ikromova, N. (2024, October). AMIGDALIN HOSILALARI SINTEZI ISTIQBOLLARI. In CONFERENCE ON THE ROLE AND IMPORTANCE OF SCIENCE IN THE MODERN WORLD (Vol. 1, No. 8, pp. 164-166).

Mo’Minjonovna, B. M., & O’G’Li, M. A. R. (2024). STUDY AND ANALYSIS OF THE PHARMACOLOGICAL PROPERTIES OF MEDICINAL PLANTS, WHICH ARE CARDIAC GLYCOSIDES USED IN CLINICAL PRACTICE. Eurasian Journal of Medical and Natural Sciences, 4(1-1), 80-83.

Raqiboyevna, G. M., & Abdulhay, M. (2025). PREVENTION OF COMPLICATIONS OF CARDIOVASCULAR DISEASES BY ORGANIZING MORPHOLOGICAL AND CLINICAL INDICATORS OF ARCUS SENILIS. Modern education and development, 26(4), 201-204.

Raqiboyevna, G. M., & Abdulhay, M. (2025, May). MORPHOLOGICAL AND CLINICAL INDICATIONS OF COMPLICATIONS OF CARDIOVASCULAR DISEASE ARCUS SENILIS. In International Conference on Multidisciplinary Sciences and Educational Practices (pp. 182-184).

Бобохонова, М. М., & Дехконбоева, К. А. (2021). НАЦИОНАЛЬНАЯ МОДЕЛЬ ОХРАНЫ ЗДОРОВЬЯ МАТЕРИ И РЕБЕНКА В УЗБЕКИСТАНЕ:" ЗДОРОВАЯ МАТЬ-ЗДОРОВЫЙ РЕБЕНОК". Экономика и социум, (10 (89)), 540-543.

Борецкая, А. С. (2022). СОСТОЯНИЕ ОБРАЗОВАНИЯ И ПЕДАГОГИЧЕСКОЙ МЫСЛИ В ЭПОХУ БЕРУНИ. Academic research in educational sciences, (3), 125-127.

Борецкая, А. С., Расулов, Ф. Х., Рузалиев, К. Н., & Хасанов, Н. Ф. У. (2024). ИММУНОГЕНЕЗ И МИКРОФЛОРА КИШЕЧНИКА ПРИ ПАТОЛОГИИ СМЕШАННОЙ ЭТИОЛОГИИ И ПУТИ ИХ КОРРЕКЦИИ. Science and innovation, 3(Special Issue 45), 276-281.

Икромова, Н. М. (2024). Научно-Теоретические Основы Социальной Адаптации Старшего Дошкольника На Основе Речевого Развития. Miasto Przyszłości, 54, 385-387.

Икромова, Н., & Эминов, Р. (2025). Влияние эмоционального интеллекта и уровня тревожности на развитие речи и социальную адаптацию детей дошкольного возраста. in Library, 1(2), 15-19.

Икромова, Н., & Эминов, Р. (2025). Развитие речи и языка у дошкольников: роль родительского взаимодействия. in Library, 1(2), 28-32.

Расулов, Ф. Х., Борецкая, А. С., Маматкулова, М. Т., & Рузибаева, Ё. Р. (2024). INFLUENCE AND STUDY OF MEDICINAL PLANTS OF UZBEKISTAN ON THE IMMUNE SYSTEM. Web of Medicine: Journal of Medicine, Practice and Nursing, 2(12), 118-124.

Расулов, Ф., Тожалиевна, М., Рузибаева, Ё., & Борецкая, А. (2024). Исследование стабильной формы коронавируса и ее устойчивости к изменчивости. Профилактическая медицина и здоровье, 3(3), 20-26.

Тешабоев, А. М., Юлчиева, С. Т., Расулов, У. М., Борецкая, А. С., & Расулов, Ф. Х. ИЗУЧЕНИЕ ИММУНОГЕНЕЗА И ГЕМОПОЭЗА У ЖИВОТНЫХ С ТИ-ПОМ АЦЕТИЛИРОВАНИЯ И ПУТИ ИХ КОРРЕКЦИИ С ОЧИЩЕННЫМ КОМПЛЕКСОМ ДЕТОКСИОМЫ.